(Q45408801)

14 December 2017

title

Non-high-density lipoprotein cholesterol independently predicts new onset of non-alcoholic fatty liver disease (English)

1 reference

non-alcoholic fatty liver

14 December 2017

1 reference

1 reference

based on heuristic

inferred from title

metabolic dysfunction–associated steatotic liver disease

1 reference

2

1 reference

14 December 2017

Shira Zelber-Sagi

1

1 reference

14 December 2017

Hanny Yeshua

3

1 reference

14 December 2017

Roni Lotan

4

1 reference

14 December 2017

Muriel Webb

5

1 reference

14 December 2017

Zamir Halpern

6

1 reference

14 December 2017

Erwin Santo

7

1 reference

14 December 2017

Ran Oren

8

1 reference

14 December 2017

Oren Shibolet

9

1 reference

14 December 2017

publication date

14 October 2013

1 reference

14 December 2017

1 reference

14 December 2017

volume

34

1 reference

14 December 2017

issue

6

1 reference

14 December 2017

page(s)

e128-35

1 reference

Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study.

14 December 2017

cites work

1 reference

NAFLD in Asia--as common and important as in the West

21 January 2018

1 reference

Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults

21 January 2018

1 reference

Functional and morphological vascular changes in pediatric nonalcoholic fatty liver disease.

21 January 2018

1 reference

Predictors for incidence and remission of NAFLD in the general population during a seven-year prospective follow-up

21 January 2018

1 reference

Physical activity recommendations, exercise intensity, and histological severity of nonalcoholic fatty liver disease

21 January 2018

1 reference

The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease.

21 January 2018

1 reference

Incidence and natural course of fatty liver in the general population: the Dionysos study.

21 January 2018

1 reference

The metabolic syndrome as a predictor of nonalcoholic fatty liver disease

21 January 2018

1 reference

Fatty liver in non-alcoholic non-overweight Japanese adults: incidence and clinical characteristics

21 January 2018

1 reference

Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: The central role of nontriglyceride fatty acid metabolites

21 January 2018

1 reference

Nonalcoholic fatty liver disease and serum lipoproteins: the Multi-Ethnic Study of Atherosclerosis

21 January 2018

1 reference

Major lipids, apolipoproteins, and risk of vascular disease

21 January 2018

1 reference

Sonographic hepatic-renal ratio as indicator of hepatic steatosis: comparison with (1)H magnetic resonance spectroscopy.

21 January 2018

1 reference

The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

21 January 2018

1 reference

Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: the Framingham Heart Study

21 January 2018

1 reference

Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis.

21 January 2018

1 reference

Mitochondrial free cholesterol loading sensitizes to TNF- and Fas-mediated steatohepatitis

21 January 2018

1 reference

Hepatic free cholesterol accumulates in obese, diabetic mice and causes nonalcoholic steatohepatitis

21 January 2018

1 reference

Increased hepatic synthesis and dysregulation of cholesterol metabolism is associated with the severity of nonalcoholic fatty liver disease

21 January 2018

1 reference

Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis

21 January 2018

1 reference

Lipid-induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet.

21 January 2018

1 reference

Synergistic interaction of dietary cholesterol and dietary fat in inducing experimental steatohepatitis

21 January 2018

1 reference

Association between dietary nutrient composition and the incidence of cirrhosis or liver cancer in the United States population.

21 January 2018

1 reference

Nutritional investigation of non-obese patients with non-alcoholic fatty liver disease: the significance of dietary cholesterol

21 January 2018

1 reference

Nutrition and nonalcoholic Fatty liver disease: the significance of cholesterol

21 January 2018

1 reference

Are dietary cholesterol intake and serum cholesterol levels related to nonalcoholic Fatty liver disease in obese children?

21 January 2018

1 reference

The liver X receptor gene team: potential new players in atherosclerosis

21 January 2018

1 reference

Nonalcoholic Fatty liver disease: focus on lipoprotein and lipid deregulation

21 January 2018

1 reference

Role of LXRs in control of lipogenesis

21 January 2018

1 reference

Central role for liver X receptor in insulin-mediated activation of Srebp-1c transcription and stimulation of fatty acid synthesis in liver.

21 January 2018

1 reference

Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis

21 January 2018

1 reference

Atorvastatin decreases serum levels of advanced glycation endproducts (AGEs) in nonalcoholic steatohepatitis (NASH) patients with dyslipidemia: clinical usefulness of AGEs as a biomarker for the attenuation of NASH.

21 January 2018

1 reference

Pharmacological cholesterol lowering reverses fibrotic NASH in obese, diabetic mice with metabolic syndrome.

21 January 2018

1 reference

Efficacy of ezetimibe for the treatment of non-alcoholic steatohepatitis: An open-label, pilot study

21 January 2018

1 reference

Efficacy of long-term ezetimibe therapy in patients with nonalcoholic fatty liver disease.

21 January 2018

1 reference

Consequences of cellular cholesterol accumulation: basic concepts and physiological implications

21 January 2018

1 reference

Sterol regulatory element-binding factor 2 (SREBF-2) predicts 7-year NAFLD incidence and severity of liver disease and lipoprotein and glucose dysmetabolism

21 January 2018

1 reference

Non-high-density lipoprotein cholesterol as a biomarker for nonalcoholic steatohepatitis

21 January 2018

1 reference

A lipidomic analysis of nonalcoholic fatty liver disease.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/LIV.12318

1 reference

14 December 2017

1 reference